0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-33.33%PremiumDec 20, 2024Expiry Date2.50Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.97Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet